Table III.
Functional annotation of the altered microRNAs in rats with acute lung injury.
| Term | Count | P-value |
|---|---|---|
| hsa05200:Pathways in cancer | 35 | 0.004 |
| hsa04010:MAPK signaling pathway | 31 | 0.002 |
| hsa04810:Regulation of actin cytoskeleton | 24 | 0.013 |
| hsa04722:Neurotrophin signaling pathway | 22 | <0.001 |
| hsa04630:JAK-STAT signaling pathway | 21 | 0.002 |
| hsa04510:Focal adhesion | 21 | 0.040 |
| hsa04310:Wnt signaling pathway | 20 | 0.004 |
| hsa04360:Axon guidance | 19 | 0.001 |
| hsa04910:Insulin signaling pathway | 18 | 0.006 |
| hsa04530:Tight junction | 17 | 0.014 |
| hsa05211:Renal cell carcinoma | 14 | <0.001 |
| hsa05210:Colorectal cancer | 14 | 0.003 |
| hsa05322:Systemic lupus erythematosus | 14 | 0.012 |
| hsa04916:Melanogenesis | 14 | 0.012 |
| hsa04012:ErbB signaling pathway | 13 | 0.010 |
| hsa05215:Prostate cancer | 13 | 0.013 |
| hsa04520:Adherens junction | 12 | 0.011 |
| hsa05217:Basal cell carcinoma | 10 | 0.008 |
| hsa05212:Pancreatic cancer | 10 | 0.045 |
MAPK, mitogen-activated protein kinase; JAK-STAT, janus kinase-signal transducer and activator of transcription.